{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:47:07Z","timestamp":1794955627953,"version":"4.9.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic lymphocytic leukemia (CLL) is a biologically heterogeneous illness with a variable clinical course. Loss of chromosomal material on chromosome 13 at cytoband 13q14 is the most frequent genetic abnormality in CLL, but the molecular aberrations underlying del13q14 in CLL remain incompletely characterized. We analyzed 171 CLL cases for loss of heterozygosity and subchromosomal copy loss on chromosome 13 in DNA from fluorescence-activated cell sorting\u2013sorted CD19+ cells and paired buccal cells using the Affymetrix XbaI 50k SNP array platform. The resulting high-resolution genomic maps, together with array-based measurements of expression levels of RNA in CLL cases with and without del13q14 and quantitative PCR\u2013based expression analysis of selected genes, support the following conclusions: (a) del13q14 is heterogeneous and composed of multiple subtypes, with deletion of Rb or the miR15a\/miR16 loci serving as anatomic landmarks, respectively; (b) del13q14 type Ia deletions are relatively uniform in length and extend from breakpoints close to the miR15a\/miR16 cluster to a newly identified telomeric breakpoint cluster at the \u223c50.2 to 50.5 Mb physical position; (c) LATS2 RNA levels are \u223c2.6-fold to 2.8-fold lower in cases with del13q14 type I that do not delete Rb, as opposed to del13q14 type II or all other CLL cases; (d) PHLPP RNA is absent in \u223c50% of CLL cases with del13q14; and (e) \u223c15% of CLL cases display marked reductions in miR15a\/miR16 expression that are often but not invariably associated with bi-allelic miR15a\/miR16 loss. These data should aid future investigations into biological differences imparted on CLL by different del13q14 subtypes. [Cancer Res 2008;68(4):1012\u201321]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-3105","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T14:07:20Z","timestamp":1203084440000},"page":"1012-1021","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14"],"prefix":"10.1158","volume":"68","author":[{"given":"Peter","family":"Ouillette","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, Division of Hematology and Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Erba","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Hematology and Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kujawski","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Hematology and Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kaminski","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Hematology and Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerby","family":"Shedden","sequence":"additional","affiliation":[{"name":"2Department of Statistics, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami N.","family":"Malek","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, Division of Hematology and Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,2,15]]},"reference":[{"key":"2022061700411052000_B1","doi-asserted-by":"crossref","unstructured":"Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med\u20082005; 352: 804\u201315.","DOI":"10.1056\/NEJMra041720"},{"key":"2022061700411052000_B2","doi-asserted-by":"crossref","unstructured":"Grever MR, Lucas DM, Dewald GW, et al. Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. J Clin Oncol\u20082007; 25: 799\u2013804.","DOI":"10.1200\/JCO.2006.08.3089"},{"key":"2022061700411052000_B3","doi-asserted-by":"crossref","unstructured":"Kienle DL, Korz C, Hosch B, et al. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes. J Clin Oncol\u20082005; 23: 3780\u201392.","DOI":"10.1200\/JCO.2005.02.568"},{"key":"2022061700411052000_B4","doi-asserted-by":"crossref","unstructured":"Mayr C, Speicher MR, Kofler DM, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood\u20082006; 107: 742\u201351.","DOI":"10.1182\/blood-2005-05-2093"},{"key":"2022061700411052000_B5","doi-asserted-by":"crossref","unstructured":"Juliusson G, Oscier DG, Fitchett M, et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med\u20081990; 323: 720\u20134.","DOI":"10.1056\/NEJM199009133231105"},{"key":"2022061700411052000_B6","doi-asserted-by":"crossref","unstructured":"Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med\u20082000; 343: 1910\u20136.","DOI":"10.1056\/NEJM200012283432602"},{"key":"2022061700411052000_B7","doi-asserted-by":"crossref","unstructured":"Chen C, Frierson HF, Jr., Haggerty PF, Theodorescu D, Gregory CW, Dong JT. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas. Genomics\u20082001; 77: 135\u201344.","DOI":"10.1006\/geno.2001.6631"},{"key":"2022061700411052000_B8","doi-asserted-by":"crossref","unstructured":"Liu Y, Hermanson M, Grander D, et al. 13q deletions in lymphoid malignancies. Blood\u20081995; 86: 1911\u20135.","DOI":"10.1182\/blood.V86.5.1911.bloodjournal8651911"},{"key":"2022061700411052000_B9","doi-asserted-by":"crossref","unstructured":"Rowntree C, Duke V, Panayiotidis P, et al. Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. Leukemia\u20082002; 16: 1267\u201375.","DOI":"10.1038\/sj.leu.2402551"},{"key":"2022061700411052000_B10","doi-asserted-by":"crossref","unstructured":"Wolf S, Mertens D, Schaffner C, et al. B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet\u20082001; 10: 1275\u201385.","DOI":"10.1093\/hmg\/10.12.1275"},{"key":"2022061700411052000_B11","doi-asserted-by":"crossref","unstructured":"Rondeau G, Moreau I, Bezieau S, et al. Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus. Mutat Res\u20082001; 458: 55\u201370.","DOI":"10.1016\/S0027-5107(01)00219-6"},{"key":"2022061700411052000_B12","doi-asserted-by":"crossref","unstructured":"Migliazza A, Bosch F, Komatsu H, et al. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood\u20082001; 97: 2098\u2013104.","DOI":"10.1182\/blood.V97.7.2098"},{"key":"2022061700411052000_B13","unstructured":"Mabuchi H, Fujii H, Calin G, et al. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Res\u20082001; 61: 2870\u20137."},{"key":"2022061700411052000_B14","unstructured":"Bullrich F, Fujii H, Calin G, et al. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res\u20082001; 61: 6640\u20138."},{"key":"2022061700411052000_B15","doi-asserted-by":"crossref","unstructured":"Kitamura E, Su G, Sossey-Alaoui K, et al. A transcription map of the minimally deleted region from 13q14 in B-cell chronic lymphocytic leukemia as defined by large scale sequencing of the 650 kb critical region. Oncogene\u20082000; 19: 5772\u201380.","DOI":"10.1038\/sj.onc.1203978"},{"key":"2022061700411052000_B16","doi-asserted-by":"crossref","unstructured":"Kapanadze B, Makeeva N, Corcoran M, et al. Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14. Genomics\u20082000; 70: 327\u201334.","DOI":"10.1006\/geno.2000.6386"},{"key":"2022061700411052000_B17","doi-asserted-by":"crossref","unstructured":"Liu Y, Corcoran M, Rasool O, et al. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene\u20081997; 15: 2463\u201373.","DOI":"10.1038\/sj.onc.1201643"},{"key":"2022061700411052000_B18","doi-asserted-by":"crossref","unstructured":"Kalachikov S, Migliazza A, Cayanis E, et al. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics\u20081997; 42: 369\u201377.","DOI":"10.1006\/geno.1997.4747"},{"key":"2022061700411052000_B19","doi-asserted-by":"crossref","unstructured":"Bouyge-Moreau I, Rondeau G, Avet-Loiseau H, et al. Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3. Genomics\u20081997; 46: 183\u201390.","DOI":"10.1006\/geno.1997.5008"},{"key":"2022061700411052000_B20","doi-asserted-by":"crossref","unstructured":"Corcoran MM, Hammarsund M, Zhu C, et al. DLEU2 encodes an antisense RNA for the putative bicistronic RFP2\/LEU5 gene in humans and mouse. Genes Chromosomes Cancer\u20082004; 40: 285\u201397.","DOI":"10.1002\/gcc.20046"},{"key":"2022061700411052000_B21","doi-asserted-by":"crossref","unstructured":"Mertens D, Wolf S, Schroeter P, et al. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood\u20082002; 99: 4116\u201321.","DOI":"10.1182\/blood.V99.11.4116"},{"key":"2022061700411052000_B22","doi-asserted-by":"crossref","unstructured":"Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A\u20082002; 99: 15524\u20139.","DOI":"10.1073\/pnas.242606799"},{"key":"2022061700411052000_B23","doi-asserted-by":"crossref","unstructured":"Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A\u20082005; 102: 13944\u20139.","DOI":"10.1073\/pnas.0506654102"},{"key":"2022061700411052000_B24","doi-asserted-by":"crossref","unstructured":"Nuckel H, Frey UH, Bau M, et al. Association of a novel regulatory polymorphism (-938C&gt;A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood\u20082007; 109: 290\u20137.","DOI":"10.1182\/blood-2006-03-007567"},{"key":"2022061700411052000_B25","doi-asserted-by":"crossref","unstructured":"Matsuzaki H, Dong S, Loi H, et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods\u20082004; 1: 109\u201311.","DOI":"10.1038\/nmeth718"},{"key":"2022061700411052000_B26","doi-asserted-by":"crossref","unstructured":"Fulci V, Chiaretti S, Goldoni M, et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood\u20082007; 109: 4944\u201351.","DOI":"10.1182\/blood-2006-12-062398"},{"key":"2022061700411052000_B27","doi-asserted-by":"crossref","unstructured":"Gao T, Furnari F, Newton AC. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell\u20082005; 18: 13\u201324.","DOI":"10.1016\/j.molcel.2005.03.008"},{"key":"2022061700411052000_B28","doi-asserted-by":"crossref","unstructured":"Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood\u20081996; 87: 4990\u20137.","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990"},{"key":"2022061700411052000_B29","doi-asserted-by":"crossref","unstructured":"Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics\u20082004; 20: 1233\u201340.","DOI":"10.1093\/bioinformatics\/bth069"},{"key":"2022061700411052000_B30","doi-asserted-by":"crossref","unstructured":"Ross CW, Ouillette PD, Saddler CM, Shedden KA, Malek SN. Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis. Clin Cancer Res\u20082007; 13: 4777\u201385.","DOI":"10.1158\/1078-0432.CCR-07-0456"},{"key":"2022061700411052000_B31","doi-asserted-by":"crossref","unstructured":"Saddler C, Ouillette P, Kujawski L, et al. Comprehensive biomarker and genomic analysis identifies P53 status as the major determinant of response to MDM2 inhibitors in chronic lymphcytic leukemia. Blood. In press 2008.","DOI":"10.1182\/blood-2007-09-112698"},{"key":"2022061700411052000_B32","doi-asserted-by":"crossref","unstructured":"Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res\u20082003; 31: e15.","DOI":"10.1093\/nar\/gng015"},{"key":"2022061700411052000_B33","doi-asserted-by":"crossref","unstructured":"Storey JD. A direct approach to false discovery rates. J R Stat Soc Ser B Meth\u20082002; 64: 479\u201398.","DOI":"10.1111\/1467-9868.00346"},{"key":"2022061700411052000_B34","doi-asserted-by":"crossref","unstructured":"Barrett T, Troup DB, Wilhite SE, et al. NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res\u20082007; 35: D760\u20135.","DOI":"10.1093\/nar\/gkl887"},{"key":"2022061700411052000_B35","doi-asserted-by":"crossref","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res\u20082002; 30: 207\u201310.","DOI":"10.1093\/nar\/30.1.207"},{"key":"2022061700411052000_B36","doi-asserted-by":"crossref","unstructured":"Hammarsund M, Corcoran MM, Wilson W, et al. Characterization of a novel B-CLL candidate gene-DLEU7-located in the 13q14 tumor suppressor locus. FEBS Lett\u20082004; 556: 75\u201380.","DOI":"10.1016\/S0014-5793(03)01371-1"},{"key":"2022061700411052000_B37","doi-asserted-by":"crossref","unstructured":"Agresti A. A survey of models for repeated ordered categorical response data. Stat Med\u20081989; 8: 1209\u201324.","DOI":"10.1002\/sim.4780081005"},{"key":"2022061700411052000_B38","doi-asserted-by":"crossref","unstructured":"Petlickovski A, Laurenti L, Li X, et al. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood\u20082005; 105: 4820\u20137.","DOI":"10.1182\/blood-2004-07-2669"},{"key":"2022061700411052000_B39","doi-asserted-by":"crossref","unstructured":"Pfeifer D, Pantic M, Skatulla I, et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood\u20082007; 109: 1202\u201310.","DOI":"10.1182\/blood-2006-07-034256"},{"key":"2022061700411052000_B40","doi-asserted-by":"crossref","unstructured":"Raghavan M, Lillington DM, Skoulakis S, et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res\u20082005; 65: 375\u20138.","DOI":"10.1158\/0008-5472.375.65.2"},{"key":"2022061700411052000_B41","doi-asserted-by":"crossref","unstructured":"Zhao X, Li C, Paez JG, et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res\u20082004; 64: 3060\u201371.","DOI":"10.1158\/0008-5472.CAN-03-3308"},{"key":"2022061700411052000_B42","doi-asserted-by":"crossref","unstructured":"Pickering MT, Kowalik TF. Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation. Oncogene\u20082006; 25: 746\u201355.","DOI":"10.1038\/sj.onc.1209103"},{"key":"2022061700411052000_B43","doi-asserted-by":"crossref","unstructured":"Hernando E, Nahle Z, Juan G, et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature\u20082004; 430: 797\u2013802.","DOI":"10.1038\/nature02820"},{"key":"2022061700411052000_B44","doi-asserted-by":"crossref","unstructured":"Yabuta N, Okada N, Ito A, et al. Lats2 is an essential mitotic regulator required for the coordination of cell division. J Biol Chem\u20082007; 282: 19259\u201371.","DOI":"10.1074\/jbc.M608562200"},{"key":"2022061700411052000_B45","doi-asserted-by":"crossref","unstructured":"Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene\u20082005; 24: 2076\u201386.","DOI":"10.1038\/sj.onc.1208445"},{"key":"2022061700411052000_B46","doi-asserted-by":"crossref","unstructured":"Jiang Z, Li X, Hu J, et al. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci Res\u20082006; 56: 450\u20138.","DOI":"10.1016\/j.neures.2006.09.006"},{"key":"2022061700411052000_B47","doi-asserted-by":"crossref","unstructured":"Takahashi Y, Miyoshi Y, Takahata C, et al. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin Cancer Res\u20082005; 11: 1380\u20135.","DOI":"10.1158\/1078-0432.CCR-04-1773"},{"key":"2022061700411052000_B48","doi-asserted-by":"crossref","unstructured":"Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev\u20082006; 20: 2687\u2013700.","DOI":"10.1101\/gad.1447006"},{"key":"2022061700411052000_B49","doi-asserted-by":"crossref","unstructured":"Ticchioni M, Essafi M, Jeandel PY, et al. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene\u20082007; 26: 7081\u201391.","DOI":"10.1038\/sj.onc.1210519"},{"key":"2022061700411052000_B50","doi-asserted-by":"crossref","unstructured":"Messmer BT, Messmer D, Allen SL, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest\u20082005; 115: 755\u201364.","DOI":"10.1172\/JCI23409"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/4\/1012\/2600517\/1012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/4\/1012\/2600517\/1012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:16:22Z","timestamp":1655432182000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/4\/1012\/542779\/Integrated-Genomic-Profiling-of-Chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,15]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,2,15]]},"published-print":{"date-parts":[[2008,2,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-3105","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22374329.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374341.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374311","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374341","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374332.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374338.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374335.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374323.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374317.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374320.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497390.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374326.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374335","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374323","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374329","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374317","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374311.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374308.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374332","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374320","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497390","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374314.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374326","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374314","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374308","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374338","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,15]]}}}